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Abstract
Background: H3K27ac histone acetylome changes contribute to the phenotypic response in heart diseases,
particularly in end-stage heart failure. However, such epigenetic alterations have not been systematically
investigated in remodeled non-failing human hearts. Therefore, valuable insight into cardiac dysfunction in early
remodeling is lacking. This study aimed to reveal the acetylation changes of chromatin regions in response to
myocardial remodeling and their correlations to transcriptional changes of neighboring genes.
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Results: We detected chromatin regions with differential acetylation activity (DARs; Padj. < 0.05) between
remodeled non-failing patient hearts and healthy donor hearts. The acetylation level of the chromatin region
correlated with its RNA polymerase II occupancy level and the mRNA expression level of its adjacent gene per
sample. Annotated genes from DARs were enriched in disease-related pathways, including fibrosis and cell
metabolism regulation. DARs that change in the same direction have a tendency to cluster together, suggesting
the well-reorganized chromatin architecture that facilitates the interactions of regulatory domains in response to
myocardial remodeling. We further show the differences between the acetylation level and the mRNA expression
level of cell-type-specific markers for cardiomyocytes and 11 non-myocyte cell types. Notably, we identified
transcriptome factor (TF) binding motifs that were enriched in DARs and defined TFs that were predicted to bind to
these motifs. We further showed 64 genes coding for these TFs that were differentially expressed in remodeled
myocardium when compared with controls.
Conclusions: Our study reveals extensive novel insight on myocardial remodeling at the DNA regulatory level.
Differences between the acetylation level and the transcriptional level of cell-type-specific markers suggest
additional mechanism(s) between acetylome and transcriptome. By integrating these two layers of epigenetic
profiles, we further provide promising TF-encoding genes that could serve as master regulators of myocardial
remodeling. Combined, our findings highlight the important role of chromatin regulatory signatures in
understanding disease etiology.
Keywords: Myocardial remodeling, Histone acetylation, Transcriptome, Transcription factor
Introduction
Myocardial remodeling is defined as changes in the size,
shape, structure, and function of the heart from cardiac
injury due to various causes [1, 2]. It is a complex
process resulting from the interplay between cardiomyo-
cytes (hypertrophy), cardiac fibroblasts (fibrosis), vascu-
lar smooth muscle cells (vascular stiffening), vascular
endothelial cells (endothelial dysfunction), and leuko-
cytes (inflammation) [2]. Pathological myocardial remod-
eling has a poor prognosis related to a higher risk of
heart failure and sudden cardiac death [3]. Given the
scarce availability of patient and control cardiac biopsies
in humans, most mechanistic studies on myocardial re-
modeling are based on animal models or cultured cells
[4–6] that do not necessarily represent the patient’s situ-
ation completely [7–9]. Human myocardial biopsies have
been used to investigate remodeling between health and
disease on the level of the methylome, transcriptome,
and proteome [10–14]. However, chromatin regulation,
defined as the dynamic modification of chromatin archi-
tecture to control gene expression [15, 16], has not been
systematically investigated. However, a previous study
mapped the epigenome in failing human hearts [17]. Al-
though the epigenetic regulation of specific classes of
genes has been suggested to contribute to the pheno-
typic response throughout the mild-stage to the end-
stage heart failure [18], there is still a lack of insight into
the early stage of cardiac dysfunction, which could be
elucidated by studying chromatin regulation changes be-
tween healthy and remodeled non-failing human hearts.
Chromatin immunoprecipitation and sequencing (ChIP-
seq) is widely utilized to study chromatin regulation [19].
Key DNA regulatory regions and pathways in several
(mostly inflammatory) diseases have been identified using
ChIP-seq [20, 21]. Histone 3 lysine 27 acetylation
(H3K27ac) is found at both active enhancers and pro-
moters, which are accessible to transcription factors (TFs),
polymerases, and other members of the transcriptional
complex in order to regulate transcription of genes [22].
Histone acetylome studies using the H3K27ac mark have
successfully identified chromatin regulation changes under
healthy and diseased conditions [23, 24]. Additionally, the
H3K27ac level correlates with gene expression levels [16].
Other histone marks that are indicative of transcription in-
clude promoter-regions-associated H3K4me3 and H3K9ac
and gene-bodies-associated H3K36me3 and H3K79me3
[25]. A recent paper further indicates that the H3K27ac
and H3K36me3 marks serve as the best predictive marks
for pathological gene programming in diseased human car-
diomyocytes when compared with other histone marks
[17]. Additionally, studies have shown that H3K27ac ex-
hibits the best correlation with both active promoters and
enhancers when compared with other marks [26, 27]. Des-
pite the rapid increase of ChIP-seq data over the last decade
[28, 29], the H3K27ac landscape that defines myocardial re-
modeling has been only scarcely investigated [17], mainly
due to the lack of proper samples and controls.
To improve our understanding of myocardial remodel-
ing at the DNA regulatory level, in this study, we employ
a ChIP-seq approach to characterize the H3K27ac bind-
ing landscape. Our findings provide new insights into
the early disease etiology, revealing genome-wide histone
acetylation changes between rare remodeled non-failing
myocardial biopsies from patients with severe aortic
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stenosis (AS) [30] and control samples from non-
transplanted donor hearts. Firstly, our study yields a
unique list of differentially acetylated regions (DARs) be-
tween these two groups. Secondly, by studying the chro-
matin dynamics, we show the well-organized chromatin
structure that physically facilitates gene regulation. En-
richment analysis using annotated genes from DARs in-
dicate altered extracellular matrix (ECM) organization
and cell metabolism regulation in remodeled myocar-
dium. Thirdly, we investigate the correlation between
histone acetylation changes and the transcriptome
changes using data from our study and published stud-
ies. Fourthly, we present the differences between the
acetylation levels and the mRNA expression level of
markers specific for cardiomyocytes and 11 non-
myocyte cell types in response to myocardial remodel-
ing, suggesting the additional mechanism(s) between
chromatin acetylation and gene transcription. Lastly, we
have identified TF binding motifs that are enriched in
DARs and genes coding for TFs predicted to bind to
these enriched motifs. Notably, 64 TF-encoding genes
are differentially expressed in remodeled myocardium
versus controls, and they may serve as candidate master
regulators of myocardial remodeling.
Results
DARs between non-failing remodeled hearts and control
hearts
We studied histone acetylation activity using H3K27ac
ChIP-seq in myocardium from AS patient hearts when
compared with control hearts, followed by multiple in
silico analyses to illustrate chromatin structural dynam-
ics and biological functions enriched by annotated genes
in remodeled myocardium (Supplementary Figure 1). On
average, we obtained 40,745 ± 9656 and 16,734 ± 6896
regions using H3K27ac ChIP-seq in control and patient
samples, respectively. Among detected H3K27ac regions,
27,879 regions were supported by at least two independ-
ent samples, out of which 11,358 unique regions showed
significantly different H3K27ac occupancy between two
groups (adjusted p value < 0.05, Fig. 1a, b, and c, Supple-
mentary Table 1). From these, we identified 5634 regions
with increased signal in patients (hyperacetylation) and
5724 regions with increased signal in controls (hypoace-
tylation). Examples of hyper- and hypoacetylated regions
are shown in Fig. 1d. This altogether demonstrates ex-
tensive changes in histone acetylation upon myocardial
remodeling.
Adjacent DARs tend to have the same direction in their
acetylation changes
A growing number of studies using chromatin conform-
ation capture techniques (i.e., 4C-seq and Hi-C) have
shown that compartments and topologically associating
domains (TADs) are tissue-specific and contain preferential
interactions of certain regulatory elements and genes [31].
Changes within and among TADs influence gene regula-
tion, and such changes have been observed in cancer [31].
We found that regions with the same direction in acetyl-
ation change upon myocardial remodeling are more likely
located next to each other (Fig. 2a, b, and c). Using the ad-
jacent (5–100 kb) peak pairs, we have found that one DAR
is more likely followed by regions with the same direction
of acetylation change when compared with randomized re-
gions (p value = 2.4e−108, Fig. 2d). Similar behavior was
also observed in more distal (100 kb–1Mb) peak pairs (p
value = 0.00012, Fig. 2d, and Supplementary Table 2). This
suggests that adjacent DARs with the same direction in
acetylation change might function together as larger regula-
tory domains or potential subdomains within TADs.
Annotated genes from DARs are well correlated with their
transcriptome changes
We performed region-to-gene annotation from DARs.
Briefly, we mapped genes located in the vicinity of DARs
using a conservative window of ± 5 kb from the transcrip-
tion start site (TSS), which is recognized to be within the
promoter region range of most genes. In total, we anno-
tated 1294 and 5886 genes in the hyper- and hypoacety-
lated regions, respectively (Supplementary Table 3).
Examples of noteworthy annotated genes in the hyper-
and hypoacetylated regions are shown in Fig. 1d.
First, we confirmed that the H3K27ac signal corre-
sponded to gene expression levels as proxied by RNA
polymerase II (RNAPII) occupancy and RNA sequencing
(RNA-seq) per sample (Fig. 3a and Supplementary Fig-
ure 3). Next, we employed gene set enrichment analysis
to examine the correlation of annotated genes from
DARs with their mRNA expression changes in the tran-
scription profiles obtained in this study and in previously
published studies [11, 12]. Based on 4240 differentially
expressed genes between patients and controls from the
RNA-seq dataset in our study (p value < 0.05, Supple-
mentary Figure 4 and Supplementary Table 4), we
showed a significant correlation between annotated
genes from the hypoacetylated regions and genes with
lower expression levels in patients (FDR < 0.001, Fig.
3b). In contrast, annotated genes from the hyperacety-
lated regions were not enriched in the pool of genes with
higher expression levels in patients when compared with
controls. However, annotated genes from the hyperace-
tylated regions showed a statistically significant correl-
ation with genes with higher expression levels in
patients when compared with controls from two pub-
lished studies (FDR = 0.007 and FDR < 0.001). There
was no significant correlation between the annotated
genes from the hypoacetylated regions in the pool of
lower expressed genes in these two studies (FDR = 0.84
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and FDR = 0.22, Fig. 3b). Taken together, these data sug-
gest that the presence of an H3K27ac signal near TSS is
positively correlated with the gene expression levels at
the same sample level (Fig. 3a), whereas changed
H3K27ac signals near TSS and differentially expressed
genes between patients and controls are not always cor-
related (Fig. 3b).
Annotated genes from DARs are enriched for remodeling-
associated biological processes
Next, we studied their enriched biological functions and
pathways (Supplementary Figure 5). The most enriched
biological functions in genes close to the hyperacetylated
regions were linked to extensive ECM regulation and
cell binding (Fig. 4a). STRING analysis identified key
gene-encoded proteins based on all genes involved in
ECM-related processes, including TGFB1, FBN1,
MFAP2, FBLN5, MFAP4, and a cluster of collagen en-
coding genes (Fig. 4c). Likewise, genes involved in
enriched Pathway and Biological Process “Hemostasis”
and “response to wounding” were annotated by STRING
to provide information on interactions in the wound
healing process (Fig. 4d). The most enriched GO Bio-
logical Processes in the hypoacetylated regions were
(See figure on previous page.)
Fig. 1 Differentially acetylated H3K27ac regions between patients and controls. a Principal component analysis (PCA) plot showing the clustering
of patient and control samples based on H3K27ac profiles (using 500 regions with the highest variance). b MA plot showing the mean
acetylation levels of all samples (x-axis) and the fold changes between two groups in the log2 scale (y-axis). Colored dots represent hyper (aqua)-
and hypoacetylated (coral) regions in patients compared with controls respectively (adjusted p value < 0.05). c Heatmap depicts the clustering of
samples based on all DARs acetylation levels. d Examples of DARs in the UCSC genome browser. Dot plots depict the acetylation level in patients
(blue) and controls (orange). ENCODE = public ENCODE data default display. H3K27ac mark = ChIP-seq data of 7 cell types obtained from
ENCODE. DHS = DNaseI hypersensitivity clusters in 125 cells. TFs = ChIP-seq data of 161 transcription factors
Fig. 2 Distribution of tandem regulated chromatin domains (TRCDs). a Manhattan plot depicting the distribution of differentially H3K27
acetylated regions in patients vs. controls: non-significant regions (grey), hyperacetylated regions (aqua), and hypoacetylated regions (coral). b
Zoomed-in view of clusters of TRCDs in the short range (indicated with the bar with higher acetylation level in patients than in controls on
chromosome 10). c Zoomed-in view of clusters of TRCDs in the short range (indicated with the bar) with lower acetylation level in patients than
in controls on chromosome 6. d Number of identified active and repressed TRCDs in short- and long-genomic distance respectively in real and
randomly distributed dataset
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summarized in Fig. 4b, and a considerable number of
them were involved in (transcriptional) regulation of
protein synthesis.
Acetylation levels and transcriptional levels per cell-type-
specific marker
To estimate from which cardiac cell type the H3K27ac
signal and RNA-seq data are mainly derived, we further
examined H3K27ac occupancy and mRNA expression
level of cell-type-specific markers in our bulk data set.
First, we collected validated markers for cardiomyocytes
and 11 types of non-myocytes as shown by two recent
studies in murine hearts in which single-cell RNA se-
quencing was used [32]. The promoter acetylation level
and the mRNA expression level of each marker per cell
type in all of our samples, in patients only, and in con-
trols only, are shown in Fig. 5a and b, respectively. Inter-
estingly, the acetylation levels of these marker genes
remained consistent among the 12 cell types, and they
were comparable between patients and controls. Their
transcriptional levels were also consistent among the 11
non-myocyte cell types and remained comparable be-
tween patients and controls. However, the mRNA ex-
pression levels of cardiomyocyte-specific markers in all
samples were more profoundly expressed when com-
pared with all non-myocyte markers, and this expression
pattern was also observed in both patients and controls.
We further highlighted the individual markers whose
nearest upstream regions were significantly differentially
acetylated (Fig. 5c) and markers whose mRNA expres-
sion levels were significantly differentially expressed be-
tween patients and controls (Fig. 5d). Out of 19
cardiomyocytes markers, the nearest chromatin regions
of 7 markers were significantly differentially acetylated,
while another 2 markers were significantly differentially
expressed (Fig. 5d). For the non-myocytes, some markers
showed significant changes in both acetylation and tran-
scriptional levels (i.e., fibroblast marker LAMC1). The
comparable acetylation and mRNA expression levels of
cell-type-specific markers between patients and controls
suggest that the cell compositions in healthy and
patient-derived cardiac tissues were not significantly dif-
ferent. Given the strikingly higher mRNA expression
levels of markers for cardiomyocytes when compared
with markers for 11 non-myocytes cell types, the RNA
data were more likely to be representative of the tran-
scriptional profile of the cardiomyocyte pool.
Discovery of transcription factor binding motifs (TFBMs)
and candidate TFs in regulating myocardial remodeling
To identify the possible upstream regulators of the ob-
served chromatin activity changes, we investigated the
occurrence of TFBMs in DARs. In total, we identified
304 and 540 TFBMs in the hyper- and hypoacetylated
regions, respectively (Supplementary Table 5). We could
assign 48 and 288 TFs with the ability to bind to TFBMs
that were exclusively overrepresented in the hyper- and
hypoacetylated regions, respectively (Fig. 6a). Also, we
could assign 231 TFs to TFBMs that were overrepre-
sented in both hyper- and hypoacetylated regions. Genes
coding for TFs that were identified in the hypoacetylated
regions significantly correlated with genes with lower
mRNA expression levels in patients when compared
with controls (FDR < 0.001, Fig. 6a). However, genes
coded for the predicted TFs from the hyperacetylated re-
gions were not enriched in the pool of upregulated
genes. By overlapping the annotated TFs in the hypera-
cetylated regions (48 + 231 = 279 in total) with the dif-
ferentially expressed genes, we identified 16 TFs (e.g.,
SMAD2 and ELF3) that were enriched in the hyperacety-
lated regions and were also presented with higher
mRNA levels in patients when compared with controls.
In addition, the overlap analysis showed that 48 anno-
tated TFs (e.g., CEBPB and KLF6) in the hypoacetylated
regions (288 + 231 = 519 in total) also showed lower
mRNA levels in patients versus controls (Fig. 6b).
To further investigate if the observed epigenetic regu-
lation is mainly derived from the cardiomyocyte pool,
we studied the involvement of those 64 TFs, which bind
to enriched TFBMs and showed altered mRNA expres-
sion levels in remodeled hearts when compared with
controls, using a gene set in hypertrophic human stem
cell-derived cardiomyocytes from a published study [33].
Four suppressed TFs identified in our study (EGR1,
EGR2, EPAS1, and ZFHX3) also showed lower mRNA
expression levels in mechanically induced hypertrophic
(See figure on previous page.)
Fig. 3 Correlation analysis of H3K27ac ChIP-seq data, RNAPII ChIP-seq data, and RNA-seq data. a Correlation between H3K27ac ChIP-seq vs.
RNAPII ChIP-seq data (left plot) and RNA-seq data (right plot) in the same sample, respectively. H3K27ac ChIP-seq data is presented on the y-axis,
whereas RNAPII ChIP-seq data and RNA-seq data are shown on the x-axis and z-axis (log2 scale). b Correlation between annotated genes from
differentially acetylated regions and differentially expressed genes from transcriptome profiles from our study and two published studies.
Differentially expressed genes per study are ranked by their fold changes and shown on the x-axis. The running correlation throughout the gene
set is shown by the curve (green) and the running enrichment score (ES) is shown in the y-axis. Enrichment score normalized for gene set size
(NES) and the false discovery rate (FDR) are shown above each plot. Black bars indicate annotated genes from differentially acetylated regions
that are presented among the transcriptome profiles
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cardiomyocytes when compared with controls. This
finding suggests that some of our identified TFs could
be highly relevant for cardiomyocytes.
Discussion
In this study, we report the first histone acetylome pro-
file based on H3K27ac ChIP-seq to reveal changed
Fig. 4 Functional analysis based on genes identified from DARs. a Top enriched Pathways and GO Biological Process based on 1924 annotated
genes in the vicinity of hyperacetylated regions that locate within a ± 5 kb range from the transcription start site. b Top enriched Pathways and
GO Biological Process based on 5885 annotated genes in the vicinity of hypoacetylated regions that locate within a ± 5 kb range from the TSS. c
Interaction of extracellular matrix-related genes, including TGFβ pathway associated genes and a cluster of collagen encoding genes detected
(STRING). d Interaction of genes that are involved in the wound healing process, gene-encoded proteins in platelet activation are indicated in red
nodes (STRING)
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chromatin activities in remodeled non-failing myocardium
from AS patients as compared to healthy donor hearts. We
identified 5634 hyperacetylated regions and 5724 hypoacety-
lated regions upon myocardial remodeling. We also showed
that reorganized chromatin regions, which changed in the
same direction in response to myocardial remodeling,
tended to cluster together. Genes annotated to these altered
regulatory regions are associated with the development of fi-
brosis formation and the regulation of cell metabolism, and
their acetylation levels are correlated with their expression
levels between patients and controls, as shown in the mRNA
data obtained from our study and published studies. We fur-
ther demonstrated the acetylation level and mRNA level of
markers specific for cardiomyocytes and 11 non-myocyte
cell populations. Lastly, by integrating the acetylome and
transcriptome datasets, we identified a list of TFs that pre-
sented with the same direction in the acetylation change
and the mRNA expression changes in remodeled myocar-
dium. Several of these TFs, such as EGR1 and EPAS1, have
already been shown to be downregulated in hypertrophic
cardiomyocytes [33]. These TFs could be promising candi-
dates in elucidating the key TFs-DNA interactions that are
involved in the pathomechanisms in remodeled myocar-
dium, and may serve as potential druggable targets for fu-
ture epigenetic therapies.
Recent studies demonstrate that alterations in chroma-
tin domains could lead to altered gene expression and
disease [34]. A review from van Steensel and Furlong on
the spatial organization of the genome showed that the
interaction between enhancer and promoter is often
found within the same TAD and subsequently regulates
transcription [35]. They further indicated the possible
influence of active transcription on the chromatin archi-
tecture within the subdomains of TADs (sub-TADs).
However, little is known about TAD regulation in hu-
man myocardium. A previous study mapped the global
chromatin structural changes in heart failure using a
murine model [36]. Here, we showed that adjacent re-
gions, which might serve as putative (sub-)TADs, were
more likely to interact in the same fashion, indicating
well-organized chromatin structures that could physic-
ally facilitate the interactions of regulatory domains. Yet,
additional studies are required to further elucidate these
identified adjacent regions as (sub-)TADs using circular
chromosome conformation capture and sequencing. We
are the first to demonstrate that differences of H3K27ac
occupancy are not limited to quantitative and qualitative
analyses of detected regions between healthy and dis-
eased conditions, but also provide insights into the
highly ordered chromatin structural rearrangements in
response to the disease.
A recent epigenetic study showed that gene expression
levels in cardiomyocytes from end-stage failing human
hearts correlated with levels of active histone marks, es-
pecially the H3K27ac mark [17]. Consistent with previ-
ous studies, we also observed that the H3K27ac
occupancy level correlated well with both RNA polymer-
ase II occupancy level using RNAPII ChIP-seq and gene
expression level using RNA-seq per sample. Using differ-
entially expressed gene profiles obtained in the present
study and from two published studies, we further ob-
served that the annotated gene set in DARs was statisti-
cally significantly correlated with differentially expressed
genes. Nevertheless, it is important to note that not all
datasets were significantly correlated, which could be
due to the different number of genes between the gene
set and the expression database and the different turn-
over ratios between histone acetylation and mRNAs
[37]. Previous epigenomic studies that aimed to identify
novel targets in heart diseases also clearly demonstrated
the importance of combining transcriptome data with
epigenetic data to reveal different perspectives of the
epigenetic regulation of the disease [38]. For example,
genes, which showed the same direction between
H3K27ac signal and expression level in patients and
controls (i.e., chr1:209,973,800-209,977,199/IRF6 and
chr16:56,639,200-56,646,949/MT2A), could improve our
understanding of the affected biological networks and
serve as potential targets for chromatin modifiers and/or
gene therapy-related strategies in remodeled hearts.
The most enriched biological processes by genes anno-
tated to the hyperacetylated regions are related to ECM
regulation. ECM organization is an important compo-
nent of cardiac remodeling, and extensive cardiac fibro-
sis is a hallmark of maladaptive hypertrophy [39, 40].
TGFβ, a key mediator in ECM formation, is regulated by
the activation of SMAD3 and the phosphorylation of
ATF2 [41]. We also identified SMAD3 in the hyperacety-
lated regions and ATF2 in the hypoacetylated regions.
An important TGFβ1-related signaling cascade is acti-
vated in cardiac fibroblasts from patients with coronary
artery disease when compared with controls, and the
(See figure on previous page.)
Fig. 5 The promoter acetylation and mRNA expression levels of cell-type-specific markers. a The acetylation levels of all makers per cell type in all
samples, patient samples, or controls. b The mRNA expression levels of all markers per cell type in all samples, patient samples, or controls. c
Markers, which showed significantly different acetylation levels at the 2.5 kb upstream window from the transcription start sites between patients
and controls, were shown. Each point represents a marker, and the fold change value was used and corresponds to the point size. d Markers,
which showed significantly different mRNA expression level between patients and controls, were shown. Each point represents a marker, and the
fold change value was used and corresponds to the point size. RPM, reads per million, which were normalized
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inhibition of IL11, a main downstream target of TGFβ1,
leads to reduced fibrosis in the heart using murine
model [42]. In line with these findings, we also observed
a higher mRNA expression level of TGFβ1 and IL11 in
patients versus controls. Furthermore, ECM homeostasis
is also regulated by a tight balance between matrix me-
talloproteinases (MMPs), which degrade ECM proteins,
and tissue inhibitors of metalloproteinases (TIMPs) [39,
43]. We annotated MMP2, MMP23A, TIMP3, and
TIMP4 in hyperacetylated regions and a group of MMPs
that showed higher mRNA expression levels in patients.
These data imply the activation of genes involved in
fibrogenic pathways at the chromatin level and tran-
scriptional level, which is in line with previous studies
that reveal a strong fibrogenic response in left ventricu-
lar remodeling [39]. Although we performed bulk se-
quencing and the histological staining showed extensive
fibrosis in remodeled myocardium, it is important to
note that cardiomyocytes also express ECM-related
genes [44]. Transcriptional processes and cell cycle were
mostly enriched by genes annotated in the hypoacety-
lated regions, indicating the downregulation of cell
metabolism in patients.
Cellular mechanotransduction has been demonstrated
in the heart, and mechanical forces are greatly increased
in AS [45, 46], suggesting the potential influence of
mechanotransduction during myocardial remodeling.
Among various pathways that are involved in the mech-
anical signaling, the Hippo pathway and its regulation of
the YAP/TAZ protein complex have been highlighted to
play a central role [46–48]. The core regulators of the
Hippo pathways, including MST1/2, SAV1, TAO-family
kinases (TAO), and MAP 4 K kinases, activate LATS1
and LATS2 kinases, which subsequently phosphorylate
YAP/TAZ, thereby stimulating proteolysis of the YAP/
TAZ complex and limiting its transcription regulatory
capacity. In our study, we observed that the chromatin
acetylation levels of MST1, MST2 (also known as
STK3), and TAOK2 were higher in patients than con-
trols. However, the mRNA expression levels of these
genes remained comparable between both groups. In
addition, the chromatin acetylation levels and the mRNA
expression levels of MAP 4 K2-5 members and LAST1/2
were not significantly changed in patient hearts when
compared with controls. Downstream targets YAP and
TAZ also showed similar chromatin acetylation and
mRNA expression levels in patient versus control hearts
(Supplementary Table 8). As we have conducted bulk se-
quencing, any subtle changes in the Hippo pathway on
single-cell type level might remain hidden. Furthermore,
changes in pathways related to mechano-activation
might mainly present itself on protein level (e.g., level of
phosphorylation of the YAP/TAZ complex). Future
single-cell (type)-sequencing-based studies in combin-
ation to proteomics studies are needed to further eluci-
date the effect of mechanical forces on different cell
types in myocardial remodeling.
Sex differences in myocardial remodeling have been
identified by previous studies [49–52]. For example,
there is a higher expression level of genes involved in fi-
brosis and inflammation in male hypertrophic hearts
compared with female hypertrophic hearts [53, 54]. In
the present study, we did not observe a sex-based clus-
tering of hearts with concentric remodeling based on
differentially acetylated regions and differentially
expressed genes (Supplementary Figure 6). This was
most likely due to the limited number of healthy hearts
from women and men (n = 2 and n = 3, respectively).
Additionally, unlike left ventricular hypertrophy, concen-
tric remodeling is defined as a normal cardiac mass des-
pite a thickened left ventricular wall [55]. Therefore, the
maladaptation of myocardial remodeling is worse in left
ventricular hypertrophy than in concentric remodeling,
which could also lead to the different observations on
the sex dimorphism between this study and previous
studies from us and others. Last but not least, the differ-
ence in location from which cardiac specimens were col-
lected between our study and previous studies may also
play a role. Combined, it is likely that the sex-specific
acetylome and transcriptome were less profound in
hearts with moderate myocardial remodeling than ad-
vanced myocardial remodeling. Certainly, future studies
are needed to investigate sex differences with additional
healthy control samples and a larger patient group size.
Notably, several TF-encoding genes that were identi-
fied in the present study have previously been shown af-
fected on the gene expression level, either in animal
models with remodeled myocardium by our group or in
(See figure on previous page.)
Fig. 6 Transcription factors (TFs) annotated from enriched transcription factor binding motifs (TFBMs) in the differentially acetylated regions
(DARs). a A Venn diagram shows the overlap of motif-encoded TFs that were linked to TFBMs found to be enriched in DARs. In the graph below
are shown the gene set enrichment analysis of genes encoding these TFs with differentially expressed genes between patients and controls.
Differentially expressed genes per study are ranked by their fold changes and shown on the x-axis. The running correlation throughout the gene
set is shown by the curve (green) and the running enrichment score (ES) is shown in the y-axis. Enrichment score normalized for gene set size
(NES) and the false discovery rate (FDR) are shown above each plot. Black bars indicate annotated genes from differentially acetylated regions
that are presented among the transcriptome profiles. b A subset of TFs that present the same direction in the acetylation activity and mRNA
expression change in remodeled myocardium as compared to the controls
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hypertrophic human stem cell-derived cardiomyocytes by
others. Previous studies showed a list of TFs with altered
mRNA expression levels in pigs with remodeled left ven-
tricle when compared with controls, such as the upregula-
tion of SMAD3 and SPIB, and the downregulation of
FOSL2, MEF2D, STAT3, and ATF7 [56, 57]. These studies
also identified TFs with significantly affected binding ac-
tivities in hypertrophic conditions using protein/DNA
array analysis, such as EGR1, ETS1, and ETS2 [57]. In line
with these reports, these same TFs were also found in the
present study, which showed matched acetylation and/or
mRNA levels changes in remodeled hearts when com-
pared with controls. Furthermore, the mRNA expression
levels of several TFs also showed consistent changing pat-
terns in hypertrophic human stem cell-derived cardio-
myocytes when compared with controls, including EGR1,
EGR2, EPAS1, and ZFHX3 [33]. The involvement of these
TFs in cardiac remodeling has also been well established
by other studies [58, 59].
Taken into account that we performed tissue-level
bulk sequencing and the cellular heterogeneity in the
heart, our data do not represent changes only in cardio-
myocytes. Recent studies have been using single-cell se-
quencing to further reveal the transcriptional landscape
per cell type in the heart, including cardiomyocytes, fi-
broblasts, and endothelial cells [60]. However, these
studies either sorted cells from freshly harvested hearts
or they isolated nuclei from snap-frozen human hearts.
Due to the difficulty of obtaining intact cells from snap-
frozen hearts, no study has shown the epigenome and/or
transcriptional regulation at the single-cell resolution in
remodeled human myocardium. Nomura and colleagues
demonstrate that the transcriptional profiles in isolated
cardiomyocytes are well correlated with the bulk tran-
scriptional profiles of murine hearts [61]. Interestingly,
by examining the mRNA expression level of markers for
cardiomyocytes and 11 non-myocytes in our bulk se-
quencing data, we observed that cardiomyocyte markers
displayed around 28–225 fold higher expression levels
than all other cell type markers, suggesting that the ma-
jority of signals at the transcriptional level was likely de-
rived from cardiomyocytes. It is important to note that
cell-type-specific markers for cardiomyocytes and 11
non-myocyte cell types were based on findings derived
from two single-cell sequencing studies using murine
hearts. Although some studies showed conserved global
gene expression between human and mouse hearts,
others have shown a poor correlation between species
[62–64]. Therefore, the analysis is limited in the way
that using cell-type-specific markers of murine hearts
may not translate one-to-one with marker expression on
human cardiac cells. Additionally, these markers were
not corrected to the number of cells per cell type. Yet,
this observation is in line with the well-correlated
transcriptional profiles between cardiomyocytes and bulk
cardiac tissues shown by Nomura et al. [61]. Although
the acetylation level of cardiomyocyte markers seemed
to be slightly higher than other cell type markers, the
profound mRNA expression pattern was not observed,
suggesting additional regulatory machinery between his-
tone acetylome and transcriptome. Additional studies on
cell-type-specific enhancers are still needed to improve
our understanding of the chromatin acetylation changes
per cell composition. Nevertheless, top enriched TFBMs
in cardiomyocytes from remodeled murine hearts after
transverse aortic constriction were also obtained in our
study [61]. The paracrine mechanisms between cardio-
myocytes and non-cardiomyocytes play an important
role in regulating cardiac function [65]. The direct cell-
to-cell crosstalks (i.e., the TGFβ signaling between car-
diac fibroblasts and cardiomyocytes), and indirect cell-
to-ECM crosstalks (i.e., via the integrin-related signal-
ing), contribute throughout the (mal) adaptive process of
cardiac remodeling [66]. Our data could offer valuable
and extensive information on these biological crosstalks.
Conclusions
In conclusion, the identified H3K27ac chromatin
regulation landscape shows significant changes in re-
modeled myocardium as compared to controls.
Enriched genes and TFBMs in the differentially acety-
lated regions highlight known disease-associated pro-
cesses, such as fibrosis. TFs that exhibited the same
direction in their acetylation and mRNA expression
changes might shed light on the upstream signaling
by providing the candidates to build and validate pu-
tative key TF-DNA networks. Taken together, the
dataset as presented here from our study provides
valuable new information and aid in the discovery of
key pathways and transcription mechanisms in the
underlying disease etiology. These findings also dem-
onstrate the value of genome-wide chromatin analysis
in understanding the molecular regulation and eti-
ology of myocardial remodeling and cardiovascular
disease in general. With the development of single-
cell sequencing techniques in biobanked patient ma-
terial and the accumulating evidence of cell-to-cell
heterogeneity within the very same cell population in
response to myocardial remodeling [29], we might
gain knowledge on the chromatin profile at the
single-cell resolution. This will allow us to examine
gene expression, protein level, and the crosstalk be-
tween multiple cell types and to investigate the cell-
to-cell variations after chromatin regulatory activity
changes and structural reorganization, further contrib-
uting to the understanding of DNA mutations in re-
gions with regulatory function and new drug target
identification for future therapies.
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Materials and methods
Study design and sample information
This study was approved by the Biobank Research Ethics
Committee of University Medical Center Utrecht (protocol
number 12/387), the Ethics Committee of UK National Re-
search Ethics Service (07/H0715/101), and the Washington
University School of Medicine Ethics Committee (Institu-
tional Review Board). Written informed consent was ob-
tained or in certain cases waived by the ethics committee
when acquiring informed consent was not possible due to
the death of the individual (control samples). All patients
with cardiac remodeling due to AS were recruited prior to
pre-operative assessment, which included a comprehensive
evaluation with clinical history, resting blood pressure, 6-
minute-walk test, electrocardiogram, transthoracic 2D-
echocardiogram, and cardiac magnetic resonance (CMR).
Inclusion criteria were patients > 18 years with severe AS (2
or more of the following: aortic valve area < 1 cm2, peak
pressure gradient > 64mmHg, mean pressure gradient >
40mmHg, aortic valve velocity ratio < 0.25) undergoing
aortic valve replacement ± coronary artery bypass grafting.
Exclusion criteria were pregnancy/breastfeeding, estimated
glomerular filtration rate < 30mL/min/1.73m2, CMR in-
compatible devices, inability to complete the protocol, pre-
vious valve surgery, or severe valve disease other than AS.
Patient samples (n = 20, 13 men and 7 women) were ob-
tained by either intraoperative scalpel or Tru-Cut needle bi-
opsy. Due to the difficulty in obtaining healthy donor
hearts, the number of control samples was limited (n = 5, 3
men and 2 women), and they were either autopsy material
or non-transplanted donor hearts without signs of cardiac
remodeling. Myocardial samples were collected and snap-
frozen in liquid nitrogen, and stored at − 80 °C. For all sam-
ples, 8-μm-thick histological slices were stained for
hematoxylin-eosin (Supplementary Figure 1). For detailed
information per sample, please refer to Supplementary
Table 6A and B.
Chromatin immunoprecipitation and sequencing
To study the changes of histone acetylome between pa-
tient and control samples, we isolated chromatin from all
frozen cardiac tissues. Briefly, all samples were sectioned
at the thickness of 10 μm and chromatin was isolated
using the MAGnify™ Chromatin Immunoprecipitation
System kit (Life Technologies) according to the manufac-
turer’s instructions. The anti-histone H3K27ac antibody
(ab4729, Abcam) was used for immunoprecipitation. Cap-
tured DNA was purified using the ChIP DNA Clean &
Concentrator kit (Zymo Research). Libraries were pre-
pared using the NEXTflex™ Rapid DNA Sequencing Kit
(Bioo Scientific). Samples were PCR amplified, checked
for the proper size range and for the absence of adaptor
dimers on a 2% agarose gel. Barcoded libraries were se-
quenced 75 bp single-end on Illumina NextSeq500
sequencer. Sequencing reads were mapped against the ref-
erence genome (hg19 assembly, NCBI37) using the BWA
package (mem –t 7 –c 100 –M –R) [67]. Multiple reads
mapping to the same location and strand were collapsed
to single read, and only uniquely placed reads were used
for peak-calling. Peaks/regions were called using Cisgen-
ome 2.0 (–e 150 -maxgap 200 –minlen 200) [68]. Region
coordinates from all samples were stretched to at least
2000 base pairs and collapsed into a single common list.
Overlapping regions were merged based on their outmost
coordinates. Only regions supported by at least 2 inde-
pendent datasets were further analyzed. Autosomal se-
quencing reads from each ChIP-seq library were
overlapped back with the common region list to set the
H3K27ac occupancy for every region-sample pair.
To further verify the detected H3K27ac signal corre-
sponds to the transcription level, we incubated chroma-
tins from 4 controls with anti-RBP1 antibody (PB-7G5),
a subunit of RNA polymerase II (RNAPII), and per-
formed the same ChIP-seq procedure [69]. To visualize
the correlation between H3K27ac and RNAPII - log2,
transformed reads per kilobase per million (RPKM) in
the gene body were correlated to H3K27ac ChIP-seq sig-
nal on gene promoters (± 2.5 kb around the TSS). For
more information, please refer to Supplementary Figure
3 and Supplementary Table 7.
Identification of differentially acetylated regions
Next, we identified regions with different H3K27ac oc-
cupancy levels between patients and controls using
DESeq2 with the standard settings (FDR Benjamini &
Hochberg Padj. < 0.05) [70]. Supervised hierarchical clus-
tering was performed with quantile normalized (limma::
normalizeQantiles() function in R), log2 transformed,
and median centered read counts per common region.
To avoid the log2 transformation of zero values, one
RPKM was added to each region. Genomic regions in
which hyper- or hypoacetylated peaks/regions located in
patients when compared with controls were defined
based on the cutoff of adjusted p < 0.05 and are referred
to as “DARs.” To visualize the clustering of the samples
based on the median centered and log2 transformed
levels of acetylation in DARs, we used heatmap.2() com-
mand from gplots package in R.
Identification of tandem regulated chromatin domains
Next, we studied the direction of the acetylation changes
in DARs to verify the chromatin spatio-temporal dynam-
ics that play an important role in gene regulation. Adja-
cent regions that had the same fold change (FC)
direction and the absolute log2FC > 0.4 were considered
as possible (sub)compartments due to the spatial
organization of the genome. Control datasets were gen-
erated by shuffling the acetylation fold change and
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significance values while retaining the locations and dis-
tances of adjacent peaks.
Region-to-gene annotation and Gene Ontology
enrichment analysis
We also performed in silico region-to-gene annotation
using a conservative window of ± 5 kb from the tran-
scription start site (TSS). Annotated gene sets were stud-
ied for their biological functions using ToppGene Suite
tool ToppFun (default setting: Probability density func-
tion, FDR correction, p value cutoff of 0.05 and gene
limit set between and including 1 and 2000 per pathway)
[71]. STRING was used to identify the key gene-encoded
proteins and their interactions within selected gene sets
(minimum required interaction score: high confidence
(0.700)) [72].
Discovery of transcription factor binding motifs and their
putative networks
In DARs, we also identified enriched transcription factor
binding motifs (TFBMs) that could elucidate the putative
networks between motif-encoded transcription factors and
genes. Briefly, repeat masked sequences of the DARs were
first overlapped with DNAse hypersensitivity site analysis
from cardiac samples from the ENCODE project [28].
DNA sequences of those overlapping DNAse sites and con-
trol shuffled sequences were taken by MEME Suite AME
tool [73] under the following settings: motif database: hu-
man (HOCOMOCO v10); background model frequencies:
0.25, 0.25, 0.25, and 0.25; total pseudo-count added to a
motif columns: 0.25; Wilcoxon rank-sum test with thresh-
old P < 0.05; number of multiple tests for Bonferroni cor-
rection: #Motifs × #Partitions Tested = 641 × 1 = 641. By
overlapping identified motifs and annotated genes from
DARs, we obtained a list of genes encoding for TFs that
were potentially master regulators of myocardial remodel-
ing at the chromatin level.
RNA sequencing and gene expression analyses
Besides the correlation between the H3K27ac signal and
RNAPII occupancy level, we also examined the H3K27ac
signal in correlation with the transcriptome level as re-
vealed by RNA sequencing (RNA-seq). Briefly, RNA was
isolated from 4 controls according to the manufacturer’s
instructions (BioLine) with minor changes. Libraries
were generated using NEXTflexTM Rapid RNA-seq Kit
(Bio Scientific) and sequenced by the Nextseq500 plat-
form (Illumina). Sequenced reads were annotated as de-
scribed previously [69]. Reads per kilobase million
(RPKM) that presented in all samples were included,
and genes with the mean RPKM > 0.5 were considered
expressed. RPKM on the log2 scale were correlated to
call reads in H3K27ac ChIP-seq using R.
To compare the transcriptional landscapes between
patient and control samples, we performed RNA-seq
using the CEL-seq protocol—an adapted single-cell
RNA-seq method that overcomes the challenge of the
low input materials due to the limited biopsy size [74].
Briefly, 10 ng RNA from each sample was used. Primer
design, linear mRNA amplification, library construction,
and sequencing were performed as described previously
[75]. Raw read file per sample was used, and differen-
tially expressed genes between patient and control hearts
were identified using the DESeq2 [70] within the Galaxy
environment under the default settings. A p value cutoff
of 0.05 was used.
Gene set enrichment analysis (GSEA)
We performed gene set enrichment analyses using GSEA
software v3.0 [76] and studied the enrichment of anno-
tated genes from DARs in relation to the gene expression
levels between patient and control hearts. TFs, from which
their TFBMs were enriched in DARs, were also examined
in the transcriptome profile. Briefly, we included genes
with significantly different expression levels as revealed by
the CEL-seq in the present study and two published stud-
ies using microarray [11, 12]. Differentially expressed
genes in each of three transcriptome profiles were ranked
based on their fold change and uploaded to GSEA as the
expression datasets. The annotated gene set from hyper-
or hypoacetylated regions was accessed for its positive or
negative enrichment throughout each expression dataset
with the standard settings.
Hypertrophic markers in cardiomyocytes during
remodeling
We also investigated candidates that could play an import-
ant role in cardiomyocytes from the bulk sequencing data.
Briefly, a list of genes that showed the same direction of
changes at the histone acetylation level and mRNA ex-
pression level was selected from our study. These genes
were overlapped with genes with altered mRNA expres-
sion levels in hypertrophic human stem cell-derived
cardiomyocytes due to mechanical stress [33].
Supplementary information
Supplementary information accompanies this paper at https://doi.org/10.
1186/s13148-020-00895-5.
Additional file 1. Supplementary Figure 1. An overview of the workflow
in this study. †Detailed information of samples used in H3K27ac ChIP-seq,
RNAPII ChIP-seq, and RNA-seq are listed in Supplementary Table 2. *:
Standard RNA-seq and adjusted RNA-seq (3′-RNA-seq) were both per-
formed, detailed information is shown in Supplementary Table 7.
Additional file 2. Supplementary Figure 2. Histology of cardiac tissues
used in this study. Overview of representative slides stained with
hematoxylin-eosin from cardiac samples in control and patient groups
are shown. Higher magnification showing normal myocardium in control
(panel A) and patient myocardium with hypertrophy of cardiomyocytes
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and interstitial fibrosis in the patient sample (panel B, both × 40
magnification).
Additional file 3. Supplementary Figure 3. Correlation plots between
H3K27ac ChIP-seq (red) with RNAPII ChIP-seq (blue) and RNA-seq datasets
(blue), respectively. Correlations in four control samples (from a to d)
used in this study. Gene expression rank is based on RPKM values.
Additional file 4 Supplementary Figure 4. The mRNA expression level of
cell-type-specific markers. Genes labeled red and blue were significantly
up- and downregulated in patients versus controls (p < 0.05).
Additional file 5. Supplementary Figure 5. Gene Ontology (GO) analysis
of genes annotated to DARs using ToppFun. a Molecular function
enrichment for hyperacetylated regions, b Biological process for
hyperacetylated regions, c Cellular component for hyperacetylated
regions, d Molecular function for hypoacetylated regions, e Biological
process for hypoacetylated regions, f Cellular component for
hypoacetylated regions.
Additional file 6. Supplementary Figure 6. Sex-specific H3K27ac acety-
lome and transcriptome profiles between male and female patients with
concentric remodeling. a Principal component analysis (PCA) plot show-
ing the clustering of man and woman cardiac samples based on
H3K27ac profiles (using 500 regions with the highest variance). b PCA
plot showing the clustering of man and woman cardiac samples based
on the transcriptome profiles (using 500 genes with the highest
variance).
Additional file 7 Supplementary Table 1. Regions with different
H3K27ac occupancy in patients compared with the control group
(adjusted p value < 0.05).
Additional file 8. Supplementary Table 2. a Identified active tandem
regulated chromatin domains (TRCDs) in the short range (5Kb–100Kb) in
patients when compared with controls. b Identified active TRCDs in the
long range (100Kb–1 Mb) in patients when compared with controls. C
Identified repressed TRCDs in the short range (5Kb–100Kb) in patients
when compared with controls. d Identified repressed TRCDs in the long
range (100Kb–1 Mb) in patients when compared with controls. e
Randomized TRCDs in the short range (5Kb–100Kb) in patients when
compared with controls. f Randomized TRCDs in the long range (100Kb–
1 Mb) in patients when compared with controls.
Additional file 9. Supplementary Table 3. a Genes in the vicinity of
hyperacetylated regions using a ± 5 kb window. b Genes in the vicinity of
hypoacetylated regions using a ± 5 kb window.
Additional file 10. Supplementary Table 4. Differentially expressed
genes between patients and controls.
Additional file 11. Supplementary Table 5. Identified transcription
binding motifs from differentially acetylated regions.
Additional file 12. Supplementary Table 6. a An overview of general
information of all included human cardiac samples. b An overview of
detailed clinical parameters of the included AS patients.
Additional file 13. Supplementary Table 7. Overview of included
samples in H3K27ac ChIP-seq, RNAPII ChIP-seq, and RNA-seq experiments.
Additional file 14. Supplementary Table 8. The chromatin acetylation
changes and the mRNA expression changes of key regulators and targets
in the Hippo pathway.
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